vs
Side-by-side financial comparison of AMERISAFE INC (AMSF) and Immunocore Holdings plc (IMCR). Click either name above to swap in a different company.
Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $80.1M, roughly 1.3× AMERISAFE INC). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 10.3%). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 2.8%).
AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
AMSF vs IMCR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $80.1M | $104.5M |
| Net Profit | $8.1M | — |
| Gross Margin | — | 97.4% |
| Operating Margin | — | -18.8% |
| Net Margin | 10.2% | — |
| Revenue YoY | 10.3% | 24.3% |
| Net Profit YoY | -9.0% | — |
| EPS (diluted) | $0.43 | $-0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $80.1M | — | ||
| Q4 25 | $81.6M | $104.5M | ||
| Q3 25 | $82.0M | $103.7M | ||
| Q2 25 | $81.1M | $98.0M | ||
| Q1 25 | $72.6M | $93.9M | ||
| Q4 24 | $74.0M | $84.1M | ||
| Q3 24 | $78.7M | $80.2M | ||
| Q2 24 | $75.8M | $75.4M |
| Q1 26 | $8.1M | — | ||
| Q4 25 | $10.4M | — | ||
| Q3 25 | $13.8M | $-177.0K | ||
| Q2 25 | $14.0M | $-10.3M | ||
| Q1 25 | $8.9M | $5.0M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $14.3M | $8.7M | ||
| Q2 24 | $11.0M | $-11.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 97.4% | ||
| Q3 25 | — | 99.5% | ||
| Q2 25 | — | 98.9% | ||
| Q1 25 | — | 99.1% | ||
| Q4 24 | — | 99.6% | ||
| Q3 24 | — | 99.4% | ||
| Q2 24 | — | 97.7% |
| Q1 26 | — | — | ||
| Q4 25 | 15.6% | -18.8% | ||
| Q3 25 | 21.3% | -6.9% | ||
| Q2 25 | 21.5% | -15.2% | ||
| Q1 25 | 15.5% | -3.9% | ||
| Q4 24 | 22.7% | -23.1% | ||
| Q3 24 | 22.6% | -10.6% | ||
| Q2 24 | 18.1% | -21.2% |
| Q1 26 | 10.2% | — | ||
| Q4 25 | 12.8% | — | ||
| Q3 25 | 16.9% | -0.2% | ||
| Q2 25 | 17.2% | -10.5% | ||
| Q1 25 | 12.3% | 5.4% | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 18.2% | 10.9% | ||
| Q2 24 | 14.5% | -15.4% |
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.55 | $-0.61 | ||
| Q3 25 | $0.72 | $0.00 | ||
| Q2 25 | $0.73 | $-0.20 | ||
| Q1 25 | $0.47 | $0.10 | ||
| Q4 24 | $0.69 | $-0.47 | ||
| Q3 24 | $0.75 | $0.17 | ||
| Q2 24 | $0.57 | $-0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.2M | $864.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.6M | $381.0M |
| Total Assets | — | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.2M | — | ||
| Q4 25 | $61.9M | $864.2M | ||
| Q3 25 | $54.7M | $892.4M | ||
| Q2 25 | $48.5M | $882.8M | ||
| Q1 25 | $44.8M | $837.0M | ||
| Q4 24 | $44.1M | $820.4M | ||
| Q3 24 | $63.7M | $901.3M | ||
| Q2 24 | $30.6M | $859.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $438.7M | ||
| Q2 24 | — | $452.5M |
| Q1 26 | $246.6M | — | ||
| Q4 25 | $251.6M | $381.0M | ||
| Q3 25 | $274.8M | $396.6M | ||
| Q2 25 | $265.6M | $388.5M | ||
| Q1 25 | $260.8M | $378.5M | ||
| Q4 24 | $257.3M | $360.7M | ||
| Q3 24 | $314.4M | $377.8M | ||
| Q2 24 | $301.0M | $359.1M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.0B | ||
| Q4 24 | $1.2B | $1.0B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.2B | $1.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.16× | ||
| Q2 24 | — | 1.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-32.7M |
| Free Cash FlowOCF − Capex | — | $-35.5M |
| FCF MarginFCF / Revenue | — | -34.0% |
| Capex IntensityCapex / Revenue | — | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-15.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.1M | $-32.7M | ||
| Q3 25 | $10.7M | $-4.5M | ||
| Q2 25 | $-8.4M | $26.0M | ||
| Q1 25 | $-1.8M | $435.0K | ||
| Q4 24 | $24.2M | $-14.0M | ||
| Q3 24 | $8.4M | $21.1M | ||
| Q2 24 | $-2.6M | $23.5M |
| Q1 26 | — | — | ||
| Q4 25 | $8.9M | $-35.5M | ||
| Q3 25 | $9.8M | $-5.2M | ||
| Q2 25 | $-9.5M | $25.6M | ||
| Q1 25 | $-1.8M | $137.0K | ||
| Q4 24 | $23.4M | $-17.5M | ||
| Q3 24 | $8.4M | $20.3M | ||
| Q2 24 | $-2.6M | $23.1M |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | -34.0% | ||
| Q3 25 | 11.9% | -5.0% | ||
| Q2 25 | -11.7% | 26.1% | ||
| Q1 25 | -2.5% | 0.1% | ||
| Q4 24 | 31.5% | -20.9% | ||
| Q3 24 | 10.7% | 25.3% | ||
| Q2 24 | -3.5% | 30.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | 2.8% | ||
| Q3 25 | 1.1% | 0.7% | ||
| Q2 25 | 1.3% | 0.4% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 1.1% | 4.3% | ||
| Q3 24 | 0.0% | 1.0% | ||
| Q2 24 | 0.1% | 0.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.06× | — | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | -0.61× | — | ||
| Q1 25 | -0.20× | 0.09× | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | 0.59× | 2.42× | ||
| Q2 24 | -0.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
